Canada NewsWire
HOUSTON, Texas and VANCOUVER, Canada , May 25, 2021 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (Nasdaq: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that Dr. David R. Parkinson , Chief Executive Officer of ESSA, will participate in a fireside chat at the upcoming Jefferies Virtual Healthcare Conference. Dr. Parkinson, along with Peter Virsik , ESSA's Chief Operating Officer, and David S. Wood , ESSA's Chief Financial Officer, will be available for one-on-one meetings. The conference will take place from June 1 – June 4, 2021 .
Fireside Chat Details:
Date: Tuesday, June 1, 2021
Time: 1:30 PM ET
A webcast of the fireside chat can be accessed on the Investors/Events & Presentations section of ESSA's website at www.essapharma.com . Following the event, the webcast will be archived on the Company's website for 90 days.
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma .
SOURCE ESSA Pharma Inc
View original content: http://www.newswire.ca/en/releases/archive/May2021/25/c0848.html